date,title,source
Oct-17-18,Bristol-Myers Squibb to Showcase Immunoscience Research and Biomarker-Guided Treatment Approaches at the 2018 American College of Rheumatology and Association of Rheumatology Health Professionals Annual Meeting,Business Wire
Oct-19-18,Bristol-Myers Squibb Provides Update on the Ongoing Regulatory Review of Opdivo Plus Low-Dose Yervoy in First-Line Lung Cancer Patients with Tumor Mutational Burden 10 mut/Mb,Business Wire
Oct-19-18,BMY vs. LLY: Which Stock Should Value Investors Buy Now?,Zacks
Oct-19-18,"Today's Research Reports on Trending Tickers: Merck & Co., and Bristol-Myers Squibb",ACCESSWIRE
Oct-22-18,[$$] Bristol-Myers Faces a Costly Delay,The Wall Street Journal
Oct-22-18,Why Nektar Therapeutics Crashed 17.2% Today,Motley Fool
Oct-22-18,Mirati Shares Fall After Cancer Trial Progress Report,TheStreet.com
Oct-22-18,MarketPulse: Healthcare Slips as Bristol-Myers Squibb Sinks,Investing.com
Oct-22-18,Bristol-Myers Slides After FDA Delays Marketing Approval for Cancer Therapy,TheStreet.com
Oct-22-18,"Dow Trades Lower After Momentum From China Rally Fades, Nasdaq Rises",TheStreet.com
Oct-22-18,Will Bristol-Myers move higher? Is Activision Blizzard ov...,CNBC Videos
Oct-22-18,[$$] Bristol-Myers Faces a Costly Delay,The Wall Street Journal
Oct-22-18,Why Mirati Therapeutics Inc. Is Plunging Today,Motley Fool
Oct-22-18,Mirati Therapeutics stock drops 19.5% after cancer trial results,MarketWatch
Oct-22-18,Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug,MarketWatch
Oct-22-18,Is a Beat in Store for Bristol-Myers (BMY) in Q3 Earnings?,Zacks
Oct-22-18,Are Bristol-Myers Squibb Companys (NYSE:BMY) Interest Costs Too High?,Simply Wall St.
Oct-22-18,Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Results in Significantly Longer Treatment-Free Survival in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma,Business Wire
Oct-22-18,Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Durable Four-Year Survival Benefits in Patients with Advanced Melanoma,Business Wire
Oct-22-18,Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Demonstrates Durable Clinical Benefit in Previously Untreated Patients with MSI-H or dMMR Metastatic Colorectal Cancer,Business Wire
Oct-23-18,"Bristol-Myers Declines, FDA Delays Review of Opdivo for NSCLC",Zacks
Oct-23-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers",Zacks
Oct-24-18,Bristol-Myers Squibb Q3 Earnings Outlook,Benzinga
Oct-24-18,"Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG",Zacks
Oct-25-18,Bristol-Myers Squibb Co (BMY) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-25-18,"Pharma Giants Merck, Bristol Diverge On Earnings Beat As Sales Lag",Investor's Business Daily
Oct-25-18,Merck and Bristol-Myers Squibb Are Seeing Rising Sales of Their Cancer Drugs,Barrons.com
Oct-25-18,"Bristol-Myers (BMY) Beats on Q3 Earnings, Raises EPS View",Zacks
Oct-25-18,"Merck, Bristol-Myers profits rise on cancer drug sales",Reuters
Oct-25-18,"Bristol-Myers Beats Q3 Earnings, Boosts Full-Year Outlook on Solid Opdivo Sales",TheStreet.com
Oct-25-18,Why Bristol-Myers Squibb (BMY) is a Top Dividend Stock for Your Portfolio,Zacks
Oct-25-18,A Spotlight On Bristol-Myers Squibb Companys (NYSE:BMY) Fundamentals,Simply Wall St.
Oct-25-18,Bristol-Myers Squibb (BMY) Q3 Earnings Beat Estimates,Zacks
Oct-26-18,"Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO",Zacks
Oct-29-18,Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know,Zacks
Oct-29-18,"The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)",Zacks
Oct-30-18,Is Halloween the Best Time to Invest? 5 Solid Buys,Zacks
Oct-31-18,The Pharmaceuticals Industry Stock Outlook: A Steady Path Ahead,Zacks
Oct-31-18,"Zacks.com highlights: Bristol-Myers Squibb, United Rentals, Capital One Financial and Harris",Zacks
Oct-31-18,"The Zacks Analyst Blog Highlights: ArcBest, Express, Arch Coal, Bristol-Myers Squibb and Methanex",Zacks
Oct-31-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Edited Transcript of BMY earnings conference call or presentation 25-Oct-18 2:30pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Bristol-Myers Squibb plans layoffs of ZymoGenetics' remaining Seattle-area employees,American City Business Journals
Nov-01-18,"Novo Nordisk (NVO) Reports In-Line Q3 Earnings, Beats Sales",Zacks
Nov-01-18,"Zoetis (ZTS) Beats on Q3 Earnings & Sales, Updates '18 View",Zacks
Nov-02-18,"AMAG Posts Wider-Than-Expected Q3 Loss, Beats on Revenues",Zacks
Nov-05-18,"Corcept (CORT) Q3 Earnings In Line, Revenues Miss Estimates",Zacks
Nov-05-18,Epizyme (EPZM) Reports Narrower-Than-Expected Loss in Q3,Zacks
Nov-05-18,"The Zacks Analyst Blog Highlights: Newfield Exploration, Amazon.com, Bristol-Myers Squibb, Eaton and CF Industries Holdings",Zacks
Nov-05-18,Bristol-Myers Squibb and Infinity Pharmaceuticals Announce a New Clinical Collaboration to Evaluate Opdivo (Nivolumab) in Combination with IPI-549 in Urothelial Cancer,PR Newswire
Nov-07-18,"Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View",Zacks
Nov-07-18,"Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer",Zacks
Nov-07-18,Why Nektar Therapeutics Fell 36.5% in October,Motley Fool
Nov-07-18,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",Benzinga
Nov-07-18,Bristol-Myers Squibb to Take Part in Credit Suisse 2018 Health Care Conference,Business Wire
